Evidence map›Paper›PMID 41318709›Full record

ArticleScientific reports2025

Multiband SERS substrate using switchable hot spots of the inline graphene-wrapped nanoparticle chains.

Mehdi Afshari-Bavil, Shiva Hayati Raad, Dong Liu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mehdi Afshari-BavilSchool of Physics Electronics Information Engineering , Neijiang Normal University , Neijiang, 641112, Sichuan, China.
Shiva Hayati RaadDepartment of Electrical and Computer Engineering , Tarbiat Modares University , Tehran, Iran.
Dong LiuKey Laboratory of Atmospheric Optics, Anhui Institute of Optics and Fine Mechanics, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, Anhui, China. dliu@aiofm.cas.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper discusses the applicability of graphene-based inline spherical trimers for the triple band single molecule detection of the analytes. The extension of the performance to the few particles' linear array assemblies with the aim of increasing the number of frequency bands and conducting hot-spot engineering is correspondingly provided. Numerical simulations show that the observed multi-band electric field intensities at the hot spots are adequately high to be used in single-molecule detection through surface-enhanced Raman scattering (SERS). Meanwhile, the few particles' linear array offers the hot spot switching capability regarding different frequencies. The generation of multiple resonances in the proposed devices is the consequence of strong coupling among the nanoparticles in the array. It is observed that to survive the higher-order resonance' detection capability, high-quality graphene shells are demanded, which is the main challenge of the experimental realization due to the imperfections introduced by the curvature of the particles. Also, to reach the single-molecule detection criteria, the use of hollow nanoparticles is a must. Importantly, multiple resonance generation employing multiple nanoparticles in the chain is not observed in the chains of plasmonic metallic particles. It is the outcome of electing graphene as the design platform since the plasmon lifetime and dissipation engineering are viable in the graphene-based devices.

Indexed as

AnalyteGrapheneLifetimeMultiplexingNanoparticleNanoparticle chainSERSTrimer

Identifiers

PMID41318709
PMCPMC12780267

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.